Login   |  Users Online: 42 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
CLINICAL RESEARCH
Year : 2012  |  Volume : 33  |  Issue : 2  |  Page : 224-229

Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis)


1 Lecturer, Department of Swasthavritta, Sri Shirdi Sai Baba Ayurvedic College, Renwal, Jaipur, Rajasthan, India
2 Lecturer, Post Graduate Department of Panchakarma, National Institute of Ayurveda, Jaipur, Rajasthan, India
3 Vice Chancellor, Rajasthan Ayurveda University, Jodhpur, Rajasthan, India

Correspondence Address:
Gopesh Mangal
Lecturer, P.G. Department owf Panchakarma, National Institute of Ayurveda, Madhav Vilas Palace, Amer Road, Jaipur - 302002, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-8520.105242

Rights and Permissions

In India an estimated 0.8% of the population is suffering from Psoriasis. It is a papulo-squamous disorder of the skin, characterized by sharply defined erythemato-squamous lesions. It is chronic and is well known for its course of remissions and exacerbations. The exact etiology is still unknown. This condition is comparable with Mandala Kushtha in Ayurvedic system of medicine. Shodhana procedures are reliable to control the disease. Forty patients, fulfilling the inclusion criteria, were selected and randomly divided into four groups with 10 patients in each group. In Group A, Vamana and Virechana was administered once during the trial period. In Group B, Vamana and Virechana followed by Dermo-care in the dose of 5 g twice a day for the period of 2 months. In Group C, only Dermo-care was administered. In Group D, Tab. Neotrexate (Methotrexate) 7.5 mg/week was given under the supervision of dermatologist. Marked improvement was observed in 10% of the patients in Group B. Moderate improvement was observed in 20% of the patients in Group A, 90% in Group B, and 80% in Group D. Mild improvement was observed in 80% of the patients in Group A, 100% in Group C, and 20% in Group D.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3132    
    Printed75    
    Emailed2    
    PDF Downloaded630    
    Comments [Add]    

Recommend this journal